Abstract:

Introduction: Interstitial lungs diseases (IAH) are the form of inflammation and fibrosis commonly in the lungs parankemia. It usually covers hundreds of chronic, clinical, radiological and pathological similar diseases. The cause of the disease can be idiopathic as it may also be related to environmental factors such as professional diseases, infections, medications. Sarkoidosis can also occur as part of autoimmune and systemic diseases, such as hereditary diseases and collagen tissue diseases. We have been in our clinic for the last five years of treatment and examining the files of 402 IAH diagnosed patients we followed. We discussed and discussed the success and success of our literature. Method: In the study, between June 2012 and June 2017, the files of patients diagnosed with interstitial lung disease, who appealed to the Breast Disease Clinic in our hospital were scaned retrospective. Results: The average age of cases was 65.21±15.44, 199 (49.5%) were women and 203 (55%) were men. In 380 patients (94.5 percent), 269 (66.9 percent) were suffering from breathing, 88 (21.9 percent) were suffering from swelling, 11 (2.7 percent) were suffering from hemopathy, and 11 (2.7 percent) were suffering from breast pain. In the lung charts, 164 (40.8%) patients had linear and reticular nodes, glazed glass nodes, crude reticular and reticular nodes, which appeared in the peripheral and lower zones. 386 patients (96) were tested for respiratory function. In the respiratory function tests 14 (3.5%) in obstructive type, 72 (17%) in respiratory function tests. 9) in the restrictive type, 120 (29.9 percent) in the mixed type, 180 (44.8 percent) in normal limits. When patients were evaluated according to IAH subdiagnoses, there were 168 (41.8%) undiference interstitial lung disease, 96 (23.9%) idiopathic pulmonary fibrosis. The result: due to the lowering of the quality of life, proper patient management is important. This disease requires a multidisciplinary approach. IAH should be remembered in patients with dry cough and breathing difficulty and with radiological interstitial attitude. Keywords: Interstitial lung diseases (ILD) is which inflammation and fibrosis are common in the lung parenchyma. It usually includes hundreds of diseases with a chronic course, clinical, radiological and pathological similarity. The causative agent may be idiopathic or may be due to environmental factors such as occupational diseases, infections, drugs. Sarcoidosis can also occur as part of autoimmune and systemic diseases such as hereditary diseases and collagen tissue diseases. In our clinic, we have examined the files of 402 patients with ILD who have been treated and followed for the last five years in our clinic. We aimed to discuss the diagnosis and success rate with the literature. Methods: The files of patients diagnosed with interstitial lung disease between June 2012 and June 2017 were analyzed retrospectively. Results: The average age of the patients was 65.21 ± 15.44 and 199 (49. 5%) were female and 203 (55%) were male. Of the patients, 380 (94.5%) had dyspnea, 269 (66.9%) had cough, 88 (21.9%) had sputum, 11 (2.7%) had hemoptysis and 11 (2.7%) had chest pain. Lung radiographs included 164 (40.8%) patients with linear and reticular opacities; Pulmonary function test was performed in 386 patients (96%). In respiratory function tests, 14 (3.5%) were obstructive type, 72 (17.9%) were in restrictive type, 120 (29.9%) in mixed type and 180 (44.8%) in normal limits. There were 168 (41.8%) undifferentiated interstitial lung disease and 96 (23.9%) patients had idiopathic pulmonary fibrosis. Keywords: Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Dispnea